You are here

Article Text

Article menu
Download PDFPDF
DTB Select
New guidelines for providing faecal microbiota transplant

https://doi.org/10.1136/dtb.2019.000039

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Review of Mullish BH et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut 2018;67:1920–41.

    Key points

    • Guidelines on providing faecal microbiota transplants for the management of recurrent or refractory Clostridium difficile infection have been published.

    • Recommendations cover recipient selection and comorbidities, donor selection and screening, faecal sample collection and storage, administration of faecal microbiota transplant and follow-up.

    New guidelines on faecal microbiota transplant from the British Society of Gastroenterology and Healthcare Infection Society provide recommendations to help standardise and optimise the procedure for treating recurrent Clostridium difficile infections.1

    Overview

    A joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) working group has developed guidelines on best practice in the provision …

    View Full Text

    Footnotes

    • Contributors: DTB Team.

    • Provenance and peer review Commissioned; Internally peer reviewed.